MedTrace Logo

A New Approach to Cervical Cancer Prevention in Kenya

NCT03942705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-06-14

No results posted yet for this study

Summary

The purpose of this study is to determine if the human papillomavirus (HPV) deoxyribonucleic acid (DNA) testing, performed on self-collected vaginal swabs, is acceptable, feasible, and sensitive and specific in detection of high-grade cervical lesions among Kenyan women, compared to the current standard of care.

Conditions

  • Healthy

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Academic Model Providing Access to Healthcare (AMPATH)

    collaborator OTHER

  • Indiana University

    lead OTHER

Principal Investigators

  • Darron Brown, MD · Indiana University

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-07
Primary Completion
2021-02-28
Completion
2021-05-31

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03942705 on ClinicalTrials.gov